Neuropsychological assessment in HTLV-1 infection: A comparative study among TSP/HAM, asymptomatic carriers, and healthy controls

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 8, 2003, Pages 1085-1089

  Silva, M T T ^a   Mattos, P ^a   Alfano, A ^a   Araujo A Q C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHROPATHY; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; MYOPATHY; NEUROPSYCHOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; UVEITIS; VERBAL MEMORY; VISUAL MEMORY; VISUOMOTOR COORDINATION;

ADULT; BRAZIL; CARRIER STATE; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HTLV-I INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYELITIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARAPARESIS, TROPICAL SPASTIC; PSYCHOMETRICS; PSYCHOMOTOR DISORDERS; REACTION TIME; REPRODUCIBILITY OF RESULTS;

EID: 0043207370     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.8.1085     Document Type: Article

References (39)

1. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Loncet 1986;i:1031-2.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-19.
3. Vernant JC, Smadja D, Deforge-Lasseur C. Vasculitis ad neurologic manifestations related to HTLV-I. Presse Med 1994;23:1421-5.
4. Mora CA, Garruto RM, Brown P, et al. Seroprevalence of antibodies to HTLV-I in patients with chronic neurological disorders other than tropical spastic paraparesis. Ann Neurol 1988;23 (suppl):S192-5.
5. Bhigjee AI, Bill PL, Wiley CA, et al. Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP). Muscle Nerve 1993;16:21-6.
6. Nakao K, Isashiki Y, Uto M, et al. [Antibodies to human T-cell lymphotropic virus type 1 in the aqueous humor of HTLV-I associated uveitis]. Nippon Ganka Gakkai Zasshi 1994;98:866-71.
7. Cartier L GA, Araya F, Castillo JL. Cognitive function in progressive spastic paraparesis associated to HTLV-I: A preliminary study. Rev Chil Neuro-Psiquiat 1992;30:241-6.
8. Cartier L, Gormoz A. [Subcortical dementia in HTLV-I tropical spastic paraparesis. Study of 43 cases]. Rev Med Chil 1999;127:444-50.
9. Castillo JL, Camposano S, Cartier L, et al. Event related potentials in progressive spastic HTLV-I positive and negative paraparesis. Rev Chil Neuro-Psiquiat 1995;33:45-50.
10. Cartier L, Gormaz A, Kleinsteuber K, et al. ][New form of subcortical dementia: encephalopathy due to infection with human lymphotropic T virus (HTLV-1). Clinical case]. Rev Med Chil 1997;125:209-13.
11. Cartier L MC, Araya F, Castillo JL, et al. Subacute encephalomyelopathy associatd with HTLV-I: pseudobulbar paralysis and mental deterioration. Neurology 1990;40 (suppl 1):238.
12. Lycke J, Svennerholm B, Svenningsson A, Horal P, et al. Possible association of HTLV-I infection and dementia. Acta Neurol Scand 1993;88:199-203.
13. Fukushima T, Uyama E, Uchino M, et al. Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-I associated myelopathy (HAM). J Neurol Sci 1994;126:30-9.
14. Kira J, Hamada T, Kawano Y, et al. An association oh HTLV-I infection with vascular dementia. Acta Neurol Scand 1997;96:305-9.
15. Sulkava R, Korpela J, Erkinjuntti T. No antibodies to HTLV-I and HIV in patients with dementia in Finland. Acta Neurol Scand 1987;76:155-6.
16. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner W, ed. Human retrovirology: HTLV. New York: Raven Press, 1990:191-7.
17. Oliveira ALA, Bastos FI, Afonso CR, et al. Measurement of neurological disbility in HTLV-I associated myelopathy: validation of a new clinical scale. AIDS Res Hum Retroviruses 2001;17:S65.
18. Lesak MD. Batteries for assessment of brain damage - batteries for assessing specific conditions/HIV+. In: Lesak MD, ed. Neuropsychological assessment. New York: Oxford Univesity Press, 1995:723.
19. Brandt J, Butters N. The neuropsychology of Huntington's disease. Trends Neurosci 1986;9:118-20.
20. Brandt J, Folstein S, Folstein M. Diferential cognitive impairment in Alzheimer's disease and Huntington's disease. Ann Neurol 1988;23:555-61.
21. Lesak MD. Neuropsychological Assessment. New York: Oxford University Press, 1995.
22. Tournier-Lasserve E, Gout O, Gessain A, et al. HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis. Lancet 1987;ii:49-50.
23. Hara Y, Takahashi M, Yoshikawa H, et al. [HTLV-I associated myelopathy with multiple spotty areas found in the cerebral white matter and brain stem by MRI]. Rinsho Shinkeigaku 1988;28:92-6.
24. Akizuki S, Setoguchi M, Nakazato O, et al. An autopsy case of human T-lymphotropic virus type I-associated myelopathy. Hum Pathol 1988;19:988-90.
25. Biddison WE, Kubota R, Kawanishi T, et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997;159:2018-25.
26. Stoolman LM. Adhesion molecules controlling lymphocyte migration. Cell 1989;56:907-10.
27. Castro-Costa CM. Fisiopatologia de la paraparesia espástica tropical asociada con el retrovirus HTLV-I. In: Zaninovic V, Castro-Costa CM, eds. La paraparesia espástica tropical o mielopatia asociada con el HTLV-I. Bogotá: Colciencias, 1998:91-115.
28. Yu F, Itoyama Y, Kira J, et al. TNF-beta produced by HTLV-I-infected cells influences the proliferation of human endothelial cells and fibroblasts. J Immunol 1994;152:5930-8.
29. Yashida S, Minakawa T, Takai N, et al. Effects of cytokines on cultured microvascular endothelial cells derived from gerbil brain. Neurosurgery 1989;25:373-7.
30. Filley CM. The behavioral neurology of cerebral white matter. Neurology 1998;50:1535-40.
31. Mesulan M-M. Prefrontal heteromodal cortex and frontal lobe syndromes: attention, executive functions and comportment. In: Mesulan M-M, ed. Principles of behavioral and cognitive neurology. 2nd edn. New York: Oxford University Press, 2000:41-9.
32. de Groat JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-51.
33. Manns A, Miley WJ, Wilks RJ, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 1999;180:1487-93.
34. Taylor GP, Tosswill JH, Matutes E, et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999;22:92-100.
35. Kramer A, Maloney EM, Morgan OS, et al. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol 1995;142;1212-20.
36. Leite AC. Prevalence study of neurologic manifestations in HTLV-I positive blood donors. Arq Neuropsiquiatr 2000;58:195.
37. Kira J, Fujihara K, Itoyama Y, et al. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 1991;106:41-9.
38. Janssen RS, Saykin AJ, Kaplan JE, et al. Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome. Ann Neurol 1988;23 (suppl):S17-8.
39. Janssen RS, Saykin AJ, Kaplan JE, et al. Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol 1988;23:49-55.